Back by Abinopharm, Inc.

Pharmaceuticals. Nutritionals. Research & Development

About AbinoNutra

Abinopharm, Inc. is a Connecticut, USA company established in 2020 with business focus in nutritional and bio pharmaceutical industries.

Our office is in Shelton, Connecticut, not far from the beautiful Yale University campus and Long Island Sound, about 1 hour drive to New York City and 2 hour drive to Boston.

Boasts an internal R&D team with over 100 years of combined experience in compliant product development and commercialization.

Collaborates with world-class experts (e.g., Prof. Andrea Maier from the National University of Singapore) on human clinical trials. Its research was awarded the 3rd Prize by the American Aging Association (AGE) in 2024.

AbinoNutra® is our brand of dietary supplements. We offer premium dietary supplements with the following unique characteristics: Products are manufactured in cGMP-certified facilities and have achieved FDA-recognized GRAS (Generally Recognized as Safe) status.

A Journey of Cellular Resilience

A vision is born

A vision is born

In 2020, Abinopharm was founded in the biotech corridor of Shelton, Connecticut, just minutes from Yale University.

One question stayed with the founders of Abinopharm and LinYi. With backgrounds in biotechnology and public health, we saw how NAD+ supplements, once moving from the lab into the market, were often repackaged as expensive “luxury elixirs of youth” reserved for the privileged few.

Health, especially the potential to support vitality and healthy aging at the cellular level, should not be a privilege. It should be as accessible as clean air and water to anyone committed to their well-being. This belief gave birth to AbinoNutra.

Science takes center stage

Science takes center stage

A talented internal research and development team with combined over 100 years experience of novel healthcare & pharmaceutical product development, regulatory compliance, and commercialization.

We also successfully conducted one of the largest human clinical trial in Collaboration with Professor Andrea Maier. More human study are under way in Taiwan and Japan. Our AbinoNutra®NMN was covered by many medias in the US and EU.

Dr.Ergo® L-Ergothioneine

Dr.Ergo® L-Ergothioneine

In collaboration with Chinese Academy Shanghai Organic Institute in China, we successfully developed a full enzymatic manufacturing process for commercial scale production of a stable and optically pure L-Ergothioneine branded as Dr.Ergo® L-Ergothioneine.

Our L-Ergothioneine is manufactured in our partner, Shanghai EGT Synbio Group, facility with US FDA registered facility under pharmaceutical cGMP guidance and was granted US FDA-recognized AS-GRAS certificate and HALAL.

We are now one of the major suppliers of L-Ergothioneine ingredient in the world.

AbinoNutra® NR

AbinoNutra® NR

With AbinoNutra®, our vision becomes reality. Consumers from US can now support their cellular health through this innovative 5 in 1 NAD+ support product (NR) which contains our first featured product Dr.Ergo® L-Ergothioneine.

Marking a meaningful space between ultra-premium longevity brands and generic white-label supplements — offering people who are open to trying affordable healthy longevity products a safe, trustworthy, and genuinely innovative choice.

AbinoNutra® NMN

AbinoNutra® NMN

The only award-winning NMN ingredient on the market with validated safety and efficacy through successful human clinical trials for promoting healthy longevity.

AbinoNutra® NMN received the 3rd prize in 2024 from the American Aging Association. A recent independent human clinical trial conducted at the University of Taipei (2026) demonstrates that NMN significantly reduces exercise-induced inflammation in young adults, expanding the application of our NMN from healthy longevity into sports nutrition。

(J. Int. Soc. Sports. Nutr. 2026; NutraIngredients 2026; Abinopharm press release 2026).

Cellular Resilience

Cellular Resilience

With the official launch of NMN in its retail packaging, our NAD+ lineup has officially grown.

We designed NR as the essential starting point for those new to healthy aging supplements, while NMN serves as the advanced formula for users with more established supplement experience.

Backed by human clinical validation, NMN has been shown to increase intracellular NAD+ by up to 4.7×, with participants demonstrating an average 4–6 year improvement in biological age markers.

By combining evidence-backed formulations with accessible pricing, we aim to make trusted longevity support available to more people.